Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ WIX UPCOMING DEADLINE: Levi & Korsinsky Alerts Wix.com Ltd. Stockholders of Securities Class Action -... (PR Newswire) +++ WIX.COM Aktie -3,39%

INNOCAN Aktie

 >INNOCAN Aktienkurs 
1.64 EUR    +6.5%    (TradegateBSX)
Ask: 1.64 EUR / 610 Stück
Bid: 1.555 EUR / 730 Stück
Tagesumsatz: 2086 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
INNOCAN Aktie über LYNX handeln
>INNOCAN Performance
1 Woche: -27,4%
1 Monat: -18,8%
3 Monate: -60,7%
6 Monate: -69,1%
1 Jahr: 0%
laufendes Jahr: -66,5%
>INNOCAN Aktie
Name:  INNOCAN PHARMA CORP.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA45783P5085 / A41FTP
Symbol/ Ticker:  IP40 (Frankfurt)
Kürzel:  FRA:IP40, ETR:IP40, IP40:GR
Index:  -
Webseite:  https://innocanpharma.com..
Profil:  InnoCan Pharma Corporation is a pharmaceutical technology company founded in 2018 and headquartered in Calgary, Canada. It specializes in innovative drug delivery platforms that combine cannabidiol (CBD) with other pharmaceutical ingredients to treat..
>Volltext..
Marktkapitalisierung:  8.19 Mio. EUR
Unternehmenswert:  5.99 Mio. EUR
Umsatz:  21.77 Mio. EUR
EBITDA:  -2.14 Mio. EUR
Nettogewinn:  -1.28 Mio. EUR
Gewinn je Aktie:  -0.28 EUR
Schulden:  1.23 Mio. EUR
Liquide Mittel:  5.81 Mio. EUR
Operativer Cashflow:  -0.33 Mio. EUR
Bargeldquote:  3.42
Umsatzwachstum:  -20.07%
Gewinnwachstum:  -113.76%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  INNOCAN
Letzte Datenerhebung:  05.08.26
>INNOCAN Kennzahlen
Aktien/ Unternehmen:
Aktien: 4.5 Mio. St.
Frei handelbar: 77.34%
Leerverk. Aktien: -
Rückkaufquote: -6.27%
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: 0.32
KBV: 1.65
PEG-Ratio: -0.04
EV/EBITDA: -
Rentabilität:
Bruttomarge: 89.81%
Gewinnmarge: -5.87%
Operative Marge: -10%
Managementeffizenz:
Gesamtkaprendite: -13.35%
Eigenkaprendite: -29.29%
>INNOCAN Peer Group
Gesundheit, Cannabis- Produkte, Neurologische Erkrankungen/ Schlaganfälle
 
05.08.26 - 15:33
 Over 100,000 Positive Verified Customer Reviews Reflect Growing Consumer Trust (PR Newswire)
 
Milestone underscores strong consumer confidence, exceptional product quality, and the Company's expanding presence in the U.S. consumer wellness market HERZLIYA, Israel and CALGARY, Alberta, Aug. 5, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ("Innocan" or......
29.07.26 - 22:06
 Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth (PR Newswire)
 
The rapidly growing skincare brand continues to strengthen its position in the U.S. beauty market through innovation, quality, and customer trust. HERZLIYA, Israel and CALGARY, AB, July 29, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan"......
27.05.26 - 22:30
 Innocan Pharma reports Q1 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.05.26 - 22:03
 Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, May 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce its......
06.05.26 - 22:03
 Innocan Pharma LPT-CBD is featured in Pain Medicine News (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, May 6, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries is pleased to announce that its novel Liposomal Delivery Platform for......
06.04.26 - 12:57
 Innocan Pharma Announces Closing of Additional Debenture (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, April 6, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its previously announced offering of an additional debenture of the Company (the......
02.04.26 - 20:12
 Innocan Pharma reports FY results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.03.26 - 16:21
 Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, March 31, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete an offering of a debenture of the Company (the "Debenture") to its largest......
31.03.26 - 09:03
 Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, March 31, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce......
16.03.26 - 22:07
 Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, March 16, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its previously announced offering of a debenture of the Company (the "Debenture") to its......
11.03.26 - 23:45
 Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, March 11, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete an offering of a debenture of the Company (the "Debenture") to its largest......
27.02.26 - 22:33
 FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary......
09.02.26 - 17:01
 Innocan Pharma gibt Ergebnisse einer randomisierten, verblindeten klinischen Studie mit Hunden bekannt: LPT-CBD ist Placebo bei Schmerzlinderung überlegen (IRW Press)
 
Herzliya, Israel und Calgary, Alberta 9. Februar 2026 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP40) (OTCQB: INNPD) (Innocan oder das Unternehmen), ein Vorreiter auf dem Gebiet der......
09.02.26 - 15:12
 Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Feb. 9, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces the publication of a research article titled......
27.01.26 - 22:18
 Innocan Pharma Corporation plant Listing an der NYSE American Stock Exchange mit gleichzeitigem Emissionsangebot (IRW Press)
 
Herzliya, Israel und Calgary, AB 27. Januar 2026 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTCQB: INNPF) (das Unternehmen oder Innocan), ein pharmazeutisches......
27.01.26 - 22:03
 Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Jan. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that,......
02.01.26 - 13:06
 Innocan Pharma Corporation plant Listing an der NYSE American Stock Exchange mit gleichzeitigem Emissionsangebot (IRW Press)
 
Herzliya, Israel und Calgary, AB - 2. Januar 2026 / IRW-Press /  Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTCQB: INNPF) (das Unternehmen oder Innocan), ein pharmazeutisches......
02.01.26 - 13:02
 Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering (PR Newswire)
 
HERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that it......
10.12.25 - 16:42
 Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering (PR Newswire)
 
HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed an amendment to its registration......
27.11.25 - 19:54
 InnoCan Pharma nach Q3-Zahlen: Kursrückgang überschattet hohe Margen und strategische Pläne (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Um einen Graben zu füllen, muß ein Hügel abgetragen werden. - Sprichwort Armenien
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!